4//SEC Filing
Jung Cassie 4
Accession 0001214659-23-006554
CIK 0001398733other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:00 PM ET
Size
6.2 KB
Accession
0001214659-23-006554
Insider Transaction Report
Form 4
Jung Cassie
Chief Operating Officer
Transactions
- Award
Performance Stock Units
2023-05-05+55,000→ 55,000 totalExp: 2026-05-05→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001960154
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:00 PM ET
- Size
- 6.2 KB